SCHEMBL23745448

SCHEMBL23745448

Cc1cccc(C(CC(=O)O)c2cn(C3CCCCC3)c3ccccc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MAPT P10636 4/20 0.41
APAF1 O14727 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
SLC6A9 P48067 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TP53 P04637 1/20 0.36
CTSA P10619 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
CCR5 P51681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23745352 0.90 HTR6 (0.43) KDM4EMEN1KMT2AGAAMGAM
SCHEMBL23745376 0.89 KDM4E (0.43) KDM4EMEN1KMT2AGAAMGAM
SCHEMBL23745609 0.84 KDM4E (0.40) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL22439066 0.84 CNR1 (0.47) KDM4EGAAMGAMSIMGAM2
SCHEMBL22439126 0.84 PRKCG (0.49) KDM4EMEN1KMT2ATP53
SCHEMBL28442806 0.80 HTR6 (0.40) KDM4EGAAMGAMSIMGAM2
SCHEMBL23721845 0.80 KDM4E (0.37) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL23721997 0.80 CCR2 (0.39) KDM4EMEN1KMT2AMAPTTP53
SCHEMBL23745728 0.80 KDM4E (0.36) KDM4EMEN1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL23722086 0.79 KDM4E (0.36) KDM4EMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 KDM4E 4474/4885MEN1 894/4885KMT2A 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.